IBDEI06F ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6263,1,4,0)
 ;;=4^N04.5
 ;;^UTILITY(U,$J,358.3,6263,2)
 ;;=^5015536
 ;;^UTILITY(U,$J,358.3,6264,0)
 ;;=N04.6^^39^446^53
 ;;^UTILITY(U,$J,358.3,6264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6264,1,3,0)
 ;;=3^Nephrotic syndrome w/ dense deposit disease
 ;;^UTILITY(U,$J,358.3,6264,1,4,0)
 ;;=4^N04.6
 ;;^UTILITY(U,$J,358.3,6264,2)
 ;;=^5015537
 ;;^UTILITY(U,$J,358.3,6265,0)
 ;;=N04.7^^39^446^54
 ;;^UTILITY(U,$J,358.3,6265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6265,1,3,0)
 ;;=3^Nephrotic syndrome w/ diffuse crescentic glomerulonephritis
 ;;^UTILITY(U,$J,358.3,6265,1,4,0)
 ;;=4^N04.7
 ;;^UTILITY(U,$J,358.3,6265,2)
 ;;=^5015538
 ;;^UTILITY(U,$J,358.3,6266,0)
 ;;=N04.8^^39^446^61
 ;;^UTILITY(U,$J,358.3,6266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6266,1,3,0)
 ;;=3^Nephrotic syndrome w/ other morphologic changes
 ;;^UTILITY(U,$J,358.3,6266,1,4,0)
 ;;=4^N04.8
 ;;^UTILITY(U,$J,358.3,6266,2)
 ;;=^5015539
 ;;^UTILITY(U,$J,358.3,6267,0)
 ;;=N04.9^^39^446^62
 ;;^UTILITY(U,$J,358.3,6267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6267,1,3,0)
 ;;=3^Nephrotic syndrome w/ unspecified morphologic changes
 ;;^UTILITY(U,$J,358.3,6267,1,4,0)
 ;;=4^N04.9
 ;;^UTILITY(U,$J,358.3,6267,2)
 ;;=^5015540
 ;;^UTILITY(U,$J,358.3,6268,0)
 ;;=N05.0^^39^446^50
 ;;^UTILITY(U,$J,358.3,6268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6268,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ minor glomerular abnormality
 ;;^UTILITY(U,$J,358.3,6268,1,4,0)
 ;;=4^N05.0
 ;;^UTILITY(U,$J,358.3,6268,2)
 ;;=^5015541
 ;;^UTILITY(U,$J,358.3,6269,0)
 ;;=N05.1^^39^446^49
 ;;^UTILITY(U,$J,358.3,6269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6269,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ focal & segmental glomerular lesions
 ;;^UTILITY(U,$J,358.3,6269,1,4,0)
 ;;=4^N05.1
 ;;^UTILITY(U,$J,358.3,6269,2)
 ;;=^5015542
 ;;^UTILITY(U,$J,358.3,6270,0)
 ;;=N05.2^^39^446^46
 ;;^UTILITY(U,$J,358.3,6270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6270,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ diffuse membranous glomrlneph
 ;;^UTILITY(U,$J,358.3,6270,1,4,0)
 ;;=4^N05.2
 ;;^UTILITY(U,$J,358.3,6270,2)
 ;;=^5015543
 ;;^UTILITY(U,$J,358.3,6271,0)
 ;;=N05.3^^39^446^47
 ;;^UTILITY(U,$J,358.3,6271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6271,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ diffuse mesangial prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,6271,1,4,0)
 ;;=4^N05.3
 ;;^UTILITY(U,$J,358.3,6271,2)
 ;;=^5015544
 ;;^UTILITY(U,$J,358.3,6272,0)
 ;;=N05.4^^39^446^45
 ;;^UTILITY(U,$J,358.3,6272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6272,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ diffuse endocaplry prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,6272,1,4,0)
 ;;=4^N05.4
 ;;^UTILITY(U,$J,358.3,6272,2)
 ;;=^5015545
 ;;^UTILITY(U,$J,358.3,6273,0)
 ;;=N05.5^^39^446^48
 ;;^UTILITY(U,$J,358.3,6273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6273,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ diffuse mesangiocap glomrlneph
 ;;^UTILITY(U,$J,358.3,6273,1,4,0)
 ;;=4^N05.5
 ;;^UTILITY(U,$J,358.3,6273,2)
 ;;=^5015546
 ;;^UTILITY(U,$J,358.3,6274,0)
 ;;=N05.6^^39^446^43
 ;;^UTILITY(U,$J,358.3,6274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6274,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ dense deposit disease
 ;;^UTILITY(U,$J,358.3,6274,1,4,0)
 ;;=4^N05.6
 ;;^UTILITY(U,$J,358.3,6274,2)
 ;;=^5015547
 ;;^UTILITY(U,$J,358.3,6275,0)
 ;;=N05.7^^39^446^44
 ;;^UTILITY(U,$J,358.3,6275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6275,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ diffuse crescentic glomrlneph
 ;;^UTILITY(U,$J,358.3,6275,1,4,0)
 ;;=4^N05.7
 ;;^UTILITY(U,$J,358.3,6275,2)
 ;;=^5015548
 ;;^UTILITY(U,$J,358.3,6276,0)
 ;;=N05.8^^39^446^51
 ;;^UTILITY(U,$J,358.3,6276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6276,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ oth morphologic changes
 ;;^UTILITY(U,$J,358.3,6276,1,4,0)
 ;;=4^N05.8
 ;;^UTILITY(U,$J,358.3,6276,2)
 ;;=^5134085
 ;;^UTILITY(U,$J,358.3,6277,0)
 ;;=N05.9^^39^446^52
 ;;^UTILITY(U,$J,358.3,6277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6277,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ unspec morphologic changes
 ;;^UTILITY(U,$J,358.3,6277,1,4,0)
 ;;=4^N05.9
 ;;^UTILITY(U,$J,358.3,6277,2)
 ;;=^5134086
 ;;^UTILITY(U,$J,358.3,6278,0)
 ;;=N06.0^^39^446^40
 ;;^UTILITY(U,$J,358.3,6278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6278,1,3,0)
 ;;=3^Isolated proteinuria w/ minor glomerular abnormality
 ;;^UTILITY(U,$J,358.3,6278,1,4,0)
 ;;=4^N06.0
 ;;^UTILITY(U,$J,358.3,6278,2)
 ;;=^5015549
 ;;^UTILITY(U,$J,358.3,6279,0)
 ;;=N06.1^^39^446^39
 ;;^UTILITY(U,$J,358.3,6279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6279,1,3,0)
 ;;=3^Isolated proteinuria w/ focal & segmental glomerular lesions
 ;;^UTILITY(U,$J,358.3,6279,1,4,0)
 ;;=4^N06.1
 ;;^UTILITY(U,$J,358.3,6279,2)
 ;;=^5015550
 ;;^UTILITY(U,$J,358.3,6280,0)
 ;;=N06.2^^39^446^36
 ;;^UTILITY(U,$J,358.3,6280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6280,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse membranous glomerulonephritis
 ;;^UTILITY(U,$J,358.3,6280,1,4,0)
 ;;=4^N06.2
 ;;^UTILITY(U,$J,358.3,6280,2)
 ;;=^5015551
 ;;^UTILITY(U,$J,358.3,6281,0)
 ;;=N06.3^^39^446^37
 ;;^UTILITY(U,$J,358.3,6281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6281,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse mesangial prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,6281,1,4,0)
 ;;=4^N06.3
 ;;^UTILITY(U,$J,358.3,6281,2)
 ;;=^5015552
 ;;^UTILITY(U,$J,358.3,6282,0)
 ;;=N06.4^^39^446^35
 ;;^UTILITY(U,$J,358.3,6282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6282,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse endocaplry prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,6282,1,4,0)
 ;;=4^N06.4
 ;;^UTILITY(U,$J,358.3,6282,2)
 ;;=^5015553
 ;;^UTILITY(U,$J,358.3,6283,0)
 ;;=N06.5^^39^446^38
 ;;^UTILITY(U,$J,358.3,6283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6283,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse mesangiocapillary glomrlneph
 ;;^UTILITY(U,$J,358.3,6283,1,4,0)
 ;;=4^N06.5
 ;;^UTILITY(U,$J,358.3,6283,2)
 ;;=^5015554
 ;;^UTILITY(U,$J,358.3,6284,0)
 ;;=N06.6^^39^446^33
 ;;^UTILITY(U,$J,358.3,6284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6284,1,3,0)
 ;;=3^Isolated proteinuria w/ dense deposit disease
 ;;^UTILITY(U,$J,358.3,6284,1,4,0)
 ;;=4^N06.6
 ;;^UTILITY(U,$J,358.3,6284,2)
 ;;=^5015555
 ;;^UTILITY(U,$J,358.3,6285,0)
 ;;=N06.7^^39^446^34
 ;;^UTILITY(U,$J,358.3,6285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6285,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse crescentic glomerulonephritis
 ;;^UTILITY(U,$J,358.3,6285,1,4,0)
 ;;=4^N06.7
 ;;^UTILITY(U,$J,358.3,6285,2)
 ;;=^5015556
 ;;^UTILITY(U,$J,358.3,6286,0)
 ;;=N06.8^^39^446^41
 ;;^UTILITY(U,$J,358.3,6286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6286,1,3,0)
 ;;=3^Isolated proteinuria w/ other morphologic lesion
 ;;^UTILITY(U,$J,358.3,6286,1,4,0)
 ;;=4^N06.8
 ;;^UTILITY(U,$J,358.3,6286,2)
 ;;=^5015557
 ;;^UTILITY(U,$J,358.3,6287,0)
 ;;=N06.9^^39^446^42
 ;;^UTILITY(U,$J,358.3,6287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6287,1,3,0)
 ;;=3^Isolated proteinuria w/ unspecified morphologic lesion
 ;;^UTILITY(U,$J,358.3,6287,1,4,0)
 ;;=4^N06.9
 ;;^UTILITY(U,$J,358.3,6287,2)
 ;;=^5015558
 ;;^UTILITY(U,$J,358.3,6288,0)
 ;;=N07.0^^39^446^30
 ;;^UTILITY(U,$J,358.3,6288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6288,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ minor glomerular abnormality
 ;;^UTILITY(U,$J,358.3,6288,1,4,0)
 ;;=4^N07.0
 ;;^UTILITY(U,$J,358.3,6288,2)
 ;;=^5015559
 ;;^UTILITY(U,$J,358.3,6289,0)
 ;;=N07.1^^39^446^29
 ;;^UTILITY(U,$J,358.3,6289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6289,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ focal & seg glomerular lesions
 ;;^UTILITY(U,$J,358.3,6289,1,4,0)
 ;;=4^N07.1
 ;;^UTILITY(U,$J,358.3,6289,2)
 ;;=^5015560
 ;;^UTILITY(U,$J,358.3,6290,0)
 ;;=N07.2^^39^446^24
